NIH-funded research R01 grant

Tracking how Cryptococcus yeast changes in HIV/AIDS patients

Official title: Evolution of Cryptococcus neoformans Strains from Patients with HIV/AIDS

Funded at Duke University · NIH-11392442 · Data updated 2026-11-12

A study to understand why Cryptococcus neoformans behaves differently in people with HIV/AIDS and how this affects disease severity and treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startAugust 8, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$792,082
NIH project number5R01AI189300-02
Project IDNIH-11392442 on NIH RePORTER

Who could benefit from this research

Could help

People with HIV/AIDS who are affected by cryptococcal meningitis and the clinical isolates collected from them.

Less likely to help

The study is largely discovery-driven; individuals not involved in or affected by cryptococcal meningitis may not directly benefit.

What this research studies

This project will collect thousands of Cryptococcus isolates from patients and the environment, sequence their genomes, and test how different strains grow and cause disease using a high-throughput setup. Researchers will link genetic differences to virulence traits and disease outcomes, building a genotype-to-phenotype map to pinpoint factors that drive meningitis severity. The work combines clinical samples, big-data genomics, and rapid phenotyping to uncover targets for better diagnostics and treatments. Patients with HIV/AIDS who develop meningitis could benefit from more precise diagnosis and future therapies informed by these findings.

Why it matters

Potential benefit: The research could lead to better diagnostic markers and new targets for antifungal therapies, improving outcomes for people with HIV/AIDS who get cryptococcal meningitis.

How similar studies have gone: Previous work shows strain differences in pathogenicity; this project expands that with a large, global isolate collection and genome-wide analyses, which is a logical next step.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Perfect, John R. — Duke University
  • Study coordinator: Perfect, John R.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.